HG

Hasmukhray Gordhandas Kariya

Active Director Director DIN 09441326
DIN 09441326 First appointment Dec 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Hasmukhray Gordhandas Kariya

Data last updated:

Hasmukhray Gordhandas Kariya is a Director at Hr Medicaid Private Limited (since 2021). The company operates in Healthcare.

DIN 09441326
Primary Designation Director
Industry Healthcare
First Appointment 20 Dec 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hr Medicaid Private Limited U85110GJ2021PTC128092
Director20 Dec 20212021Active

Board colleagues of Hasmukhray Gordhandas Kariya

NameDINCompanyDesignation
Ranjanben Hasamukhrai Karia09441327Hr Medicaid Private LimitedDirector

Directorship timeline

Open interactive timeline →
Hr Medicaid Private Limited
Premium access

Shareholding and investment profile for Hasmukhray Gordhandas Kariya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hasmukhray Gordhandas Kariya

Hasmukhray Gordhandas Kariya currently holds 1 directorship: Hr Medicaid Private Limited (Director, since 20 Dec 2021).

Hasmukhray Gordhandas Kariya was first appointed on 20 Dec 2021 as Director at Hr Medicaid Private Limited.

The current boards of Hasmukhray Gordhandas Kariya's companies include Ranjanben Hasamukhrai Karia (Hr Medicaid Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available